Transformations in Translational Neuroscience

Alzheimer's Disease & Dementia NIH Funding Opportunities

RFA-AG-18-022: Understanding the Effects of ApoE2 on the Interaction between Aging and Alzheimer’s Disease (R01).

PAR-18-516: Human Cell Biology of Alzheimer's Disease Genetic Variants (R01).

PA-18-348: Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01).

PAR-18-513: Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required).

Research on Autism Spectrum Disorders- R01, R21 & R03 opportunities

The purpose of this Funding Opportunity Announcement (FOA) is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, and optimal means of service delivery in relation to Autism Spectrum Disorders (ASD). Basic research into the pathophysiology of ASD, including research on brain mechanisms and genetics, is of special interest. Also of high priority are clinical and applied investigations that may lead to the development of new treatments and interventions.

https://grants.nih.gov/grants/guide/pa-files/PA-18-401.html

NINDS Program Project Grant (P01)

This funding opportunity announcement (FOA) is issued by the National Institute of Neurological Disorders and Stroke to enable submission of program project grant applications that propose to conduct innovative, interactive research to answer significant scientific questions that are important for the mission of NINDS, via a synergistic collaboration between outstanding scientists who might not otherwise collaborate. The program project grant is designed to support research in which the funding of several interdependent highly meritorious projects as a group offers significant scientific advantages over support of these same projects as individual research grants.

https://grants.nih.gov/grants/guide/pa-files/PAR-18-421.html

BHI Faculty Candidate Seminar

Wednesday, May 23, 12 PM - 1 PM. Room 3B, (Third Floor), School of Public Health Bldg., 683 Hoes Lane West, Piscataway. "Novel Mechanisms in the Regulation of Aversive Behaviors" Ipe Ninan, PhD, NYU-School of Medicine, NY.

Rutgers-Princeton Computational Cognitive Neuropsychiatry meeting

Bi-weekly meetings on Wednesdays from 10-11 AM. Meeting schedule available here

  • Chairman’s Conference Room, D-203, Psychiatry/UBHC building, 671 Hoes Lane West, Piscataway, NJ
  • For those who cannot attend in person, we use GoToMeetings. Please click this link to join the meeting- https://global.gotomeeting.com/join/649315085
  • You can also dial in using your phone -

    United States: +1 (646) 749-3129
    Germany: +49 (0) 692 5736 7210
    United Kingdom: +44 (0) 330 221 0090

    Question?- contact us at- silvers1@ubhc.rutgers.edu

The 2017-2018 BHI Plenary seminar series

New!! The schedule for the 2017-2018 BHI Plenary Seminar Series is available now. Check out the prominent neuroscientists BHI will be hosting this year.

BHI Plenary Seminar

Thursday, May 10th, 2 PM - 3 PM. Room B610, MSB, New Jersey Medical School, 185 S. Orange Ave, Newark. "Therapeutic Approaches to Modifying the Progression of Parkinson’s Disease" Anthony E. Lang, MD, University of Toronto, Toronto Western Hospital, Canada.